#Latest news with #1093HKReuters3 days agoBusinessReutersAstraZeneca agrees to research deal worth up to $5.22 billion with CSPCJune 13 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Friday it has agreed to a research deal with Chinese drugmaker CSPC Pharmaceuticals ( opens new tab worth up to $5.22 billion to focus on AI-enabled initiatives.
Reuters3 days agoBusinessReutersAstraZeneca agrees to research deal worth up to $5.22 billion with CSPCJune 13 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Friday it has agreed to a research deal with Chinese drugmaker CSPC Pharmaceuticals ( opens new tab worth up to $5.22 billion to focus on AI-enabled initiatives.